Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,472.00",
    "chg": 91.4,
    "chgp": "1.43%",
    "dir": 1,
    "prev_price": "6,380.60",
    "mcapval": "174,785.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE361B01024",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "8.06 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Sees Notable Surge in Open Interest Amid Rising Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-rising-market-momentum-3763965",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_oi_spurts_by_underlying_3763965.png",
        "date": "2025-12-19 12:00:08",
        "description": "Divis Laboratories has experienced a significant surge in open interest within its derivatives segment, reflecting heightened market participation and evolving positioning among investors. This development coincides with the stock’s recent outperformance relative to its sector and broader indices, signalling increased attention from market participants in the Pharmaceuticals & Biotechnology space."
      },
      {
        "title": "Divis Laboratories Sees Heavy Put Option Activity Ahead of December Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-heavy-put-option-activity-amid-mixed-market-signals-3763968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_most_active_stocks_puts_3763968.png",
        "date": "2025-12-19 12:00:07",
        "description": "Divis Laboratories Ltd has emerged as the most active stock in put options trading as the December 2025 expiry approaches, signalling notable investor positioning in the pharmaceuticals sector. The surge in put contracts at the 6,500 strike price highlights a cautious stance amid recent price movements and market dynamics."
      },
      {
        "title": "Divis Laboratories Sees Notable Surge in Open Interest Amid Rising Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-momentum-3763896",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_oi_spurts_by_underlying_3763896.png",
        "date": "2025-12-19 11:00:08",
        "description": "Divis Laboratories has experienced a significant rise in open interest within its derivatives segment, coinciding with a positive price trajectory and increased investor participation. This development highlights evolving market positioning and potential directional bets in the pharmaceutical sector."
      },
      {
        "title": "Divis Laboratories Sees Robust Trading Activity Amid Pharmaceutical Sector Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-robust-trading-activity-amid-institutional-interest-3763770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_most_active_equities_by_value_3763770.png",
        "date": "2025-12-19 10:00:16",
        "description": "Divis Laboratories has emerged as one of the most actively traded stocks by value in the Indian equity market, reflecting heightened investor interest and strong liquidity within the Pharmaceuticals & Biotechnology sector. The stock's recent trading session demonstrated notable price movement and volume dynamics, underscoring its significance among large-cap pharmaceutical companies."
      },
      {
        "title": "Divis Laboratories Sees Robust Call Option Activity Amid Bullish Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-robust-call-option-activity-amid-bullish-momentum-3763628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_most_active_stocks_calls_3763628.png",
        "date": "2025-12-19 10:00:12",
        "description": "Divis Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has attracted significant attention in the derivatives market with heavy call option trading ahead of the December expiry. The stock’s underlying value, combined with active strike prices and rising investor participation, signals a bullish positioning among market participants as it outperforms its sector and broader indices."
      },
      {
        "title": "Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-momentum-3763609",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_oi_spurts_by_underlying_3763609.png",
        "date": "2025-12-19 10:00:08",
        "description": "Divis Laboratories has experienced a significant rise in open interest within its derivatives segment, reflecting heightened market activity and evolving investor positioning. This development coincides with the stock’s recent outperformance relative to its sector and broader indices, signalling increased interest from market participants in the pharmaceutical and biotechnology space."
      },
      {
        "title": "Divis Laboratories Hits Intraday High with Strong 3.3% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-hits-intraday-high-with-33-surge-on-19-dec-2025-3763509",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_priceRelatedfactors_3763509.png",
        "date": "2025-12-19 09:32:23",
        "description": "Divis Laboratories demonstrated robust intraday performance on 19 Dec 2025, touching a high of Rs 6,592, reflecting a 3.31% rise during the trading session. The stock outpaced its sector and broader market indices, supported by notable volatility and sustained momentum across multiple moving averages."
      },
      {
        "title": "Divis Laboratories Hits Intraday High with Strong 3.17% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-hits-intraday-high-with-strong-314-surge-on-11-dec-2025-3756477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_priceRelatedfactors_3756477.png",
        "date": "2025-12-11 12:21:11",
        "description": "Divis Laboratories demonstrated robust intraday performance on 11 Dec 2025, reaching a day’s high of Rs 6,491.9, reflecting a 3.17% rise. The stock outpaced its sector and broader market indices, supported by sustained buying momentum and favourable technical indicators."
      },
      {
        "title": "Divis Laboratories Hits Intraday Low Amid Price Pressure and Market Headwinds",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-hits-intraday-low-amid-price-pressure-on-8-dec-2025-3751667",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DivisLaboratori_priceRelatedfactors_3751667.png",
        "date": "2025-12-08 15:01:37",
        "description": "Shares of Divis Laboratories experienced a notable decline today, touching an intraday low of Rs 6,275.45 as the stock faced downward pressure amid broader market weakness and sector-specific dynamics."
      }
    ],
    "total": 536,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Regulation 30 Disclosure - US-FDA Inspection Of CompanyS Unit-I Manufacturing Facility At Lingojigudem Village Yadadri Bhuvanagiri District Telangana India",
      "datetime": "14-Nov-2025",
      "details": "As per enclosed letter.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "12-Nov-2025",
      "details": "Submission of transcript of Q2FY26 earnings conference call held on November 07 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Nov-2025",
      "details": "Newspaper clippings regarding unaudited financial results for the quarter and half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Sees Notable Surge in Open Interest Amid Rising Market Activity

2025-12-19 12:00:08

Divis Laboratories has experienced a significant surge in open interest within its derivatives segment, reflecting heightened market participation and evolving positioning among investors. This development coincides with the stock’s recent outperformance relative to its sector and broader indices, signalling increased attention from market participants in the Pharmaceuticals & Biotechnology space.

Divis Laboratories Sees Heavy Put Option Activity Ahead of December Expiry

2025-12-19 12:00:07

Divis Laboratories Ltd has emerged as the most active stock in put options trading as the December 2025 expiry approaches, signalling notable investor positioning in the pharmaceuticals sector. The surge in put contracts at the 6,500 strike price highlights a cautious stance amid recent price movements and market dynamics.

Divis Laboratories Sees Notable Surge in Open Interest Amid Rising Market Momentum

2025-12-19 11:00:08

Divis Laboratories has experienced a significant rise in open interest within its derivatives segment, coinciding with a positive price trajectory and increased investor participation. This development highlights evolving market positioning and potential directional bets in the pharmaceutical sector.

Divis Laboratories Sees Robust Trading Activity Amid Pharmaceutical Sector Momentum

2025-12-19 10:00:16

Divis Laboratories has emerged as one of the most actively traded stocks by value in the Indian equity market, reflecting heightened investor interest and strong liquidity within the Pharmaceuticals & Biotechnology sector. The stock's recent trading session demonstrated notable price movement and volume dynamics, underscoring its significance among large-cap pharmaceutical companies.

Divis Laboratories Sees Robust Call Option Activity Amid Bullish Market Sentiment

2025-12-19 10:00:12

Divis Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has attracted significant attention in the derivatives market with heavy call option trading ahead of the December expiry. The stock’s underlying value, combined with active strike prices and rising investor participation, signals a bullish positioning among market participants as it outperforms its sector and broader indices.

Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Rising Market Momentum

2025-12-19 10:00:08

Divis Laboratories has experienced a significant rise in open interest within its derivatives segment, reflecting heightened market activity and evolving investor positioning. This development coincides with the stock’s recent outperformance relative to its sector and broader indices, signalling increased interest from market participants in the pharmaceutical and biotechnology space.

Divis Laboratories Hits Intraday High with Strong 3.3% Surge

2025-12-19 09:32:23

Divis Laboratories demonstrated robust intraday performance on 19 Dec 2025, touching a high of Rs 6,592, reflecting a 3.31% rise during the trading session. The stock outpaced its sector and broader market indices, supported by notable volatility and sustained momentum across multiple moving averages.

Divis Laboratories Hits Intraday High with Strong 3.17% Surge

2025-12-11 12:21:11

Divis Laboratories demonstrated robust intraday performance on 11 Dec 2025, reaching a day’s high of Rs 6,491.9, reflecting a 3.17% rise. The stock outpaced its sector and broader market indices, supported by sustained buying momentum and favourable technical indicators.

Divis Laboratories Hits Intraday Low Amid Price Pressure and Market Headwinds

2025-12-08 15:01:37

Shares of Divis Laboratories experienced a notable decline today, touching an intraday low of Rs 6,275.45 as the stock faced downward pressure amid broader market weakness and sector-specific dynamics.

View All News